Excellent agreement between genetic and hydrogen breath tests.pdfVIP

下载本文档

10
0
约3.72万字
约 8页
2017-04-13 发布于江苏
举报
版权申诉

Excellent agreement between genetic and hydrogen breath tests.pdf

1、有哪些信誉好的足球投注网站（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

Excellent agreement between genetic and hydrogen breath tests

Excellent agreement between genetic and hydrogen breath tests for lactase deficiency and the role of extended symptom assessment D. Pohl1,2*, E. Savarino1,3, M. Hersberger4, Z. Behlis1, B. Stutz1, O. Goetze1, A. v. Eckardstein5, M. Fried1 and R. Tutuian1,6 1Division of Gastroenterology and Hepatology, University Hospital Zurich, Raemistrasse 100, 8091 Zu?rich, Switzerland 2Division of Gastroenterology and Hepatology, Digestive Disease Center, Medical University of South Carolina, Charleston, SC, USA 3Division of Gastroenterology and Hepatology, University of Genoa, Genoa, Italy 4Division of Clinical Chemistry and Biochemistry, University Children’s Hospital, Zurich, Switzerland 5Institute of Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland 6University Clinic for Visceral Surgery and Medicine, Bern University Hospital, Inselspital, Bern, Switzerland (Received 15 September 2009 – Revised 1 March 2010 – Accepted 15 March 2010 – First published online 19 April 2010) Clinical manifestations of lactase (LCT) deficiency include intestinal and extra-intestinal symptoms. Lactose hydrogen breath test (H2-BT) is considered the gold standard to evaluate LCT deficiency (LD). Recently, the single-nucleotide polymorphism C/T213 910 has been associated with LD. The objectives of the present study were to evaluate the agreement between genetic testing of LCT C/T213 910 and lactose H2-BT, and the diagnostic value of extended symptom assessment. Of the 201 patients included in the study, 194 (139 females; mean age 38, range 17–79 years, and 55 males, mean age 38, range 18–68 years) patients with clinical suspicion of LD underwent a 3–4 h H2-BT and genetic testing for LCT C/T213 910. Patients rated five intestinal and four extra-intestinal symptoms during the H2-BT and then at home for the following 48 h. Declaring H2-BT as the gold standard, the CC213 910 genotype had a sensitivity of 97 % and a specificity of 95 % with a k of 0·9 in diagnosing LCT deficiency. Patie